GenMark Diagnostics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

GenMark Diagnostics, Inc. (NASDAQ: GNMK) announced its participation in two investor conferences. Management will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 5:20 p.m. ET, and at the 23rd Annual Needham Growth Conference on January 14, 2021, at 5:00 p.m. ET. Both presentations will be available via live and archived webcasts at ir.genmarkdx.com. GenMark specializes in multiplex molecular diagnostic solutions aimed at enhancing patient care and reducing healthcare costs through innovative testing systems.

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences.

GenMark’s management is scheduled to present at the 39^th Annual J.P. Morgan Healthcare Conference in a virtual setting on Tuesday, January 12^th, 2021 at 5:20 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.

GenMark’s management is also scheduled to present at the 23^rd Annual Needham Growth Conference in a virtual setting on Thursday, January 14, 2021 at 5:00 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.

ABOUT GENMARK

GenMark is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor^® detection technology, GenMark's eSensor XT-8^® and ePlex^® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.  For more information, visit www.genmarkdx.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com

FAQ

When will GenMark Diagnostics present at the J.P. Morgan Healthcare Conference?

GenMark Diagnostics will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 5:20 p.m. ET.

What is the date and time of GenMark's presentation at the Needham Growth Conference?

GenMark will present at the 23rd Annual Needham Growth Conference on January 14, 2021, at 5:00 p.m. ET.

Where can I access the webcast of GenMark's investor presentations?

The live and archived webcasts of GenMark's presentations can be accessed at ir.genmarkdx.com.

What technology does GenMark use for its diagnostic testing systems?

GenMark utilizes its proprietary eSensor® detection technology for its diagnostic testing systems.

What are the key benefits of GenMark's ePlex system?

GenMark's ePlex system is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs.